Pricing Log in Create free account
Saturday 17 October 2026 Export BDX’s income statement to Excel — free account

Becton, Dickinson and Company

BDX Healthcare Medical Instruments & Supplies

In the quarter to June 2026, revenue grew 5.44%, EPS fell 31.5%, free cash flow fell 31.6% and total debt fell 22.9%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for three.

191.75 2.01 −1.04%
Market cap
$52.8B
P/E
57.8×
Fwd P/E
37.7×
Dividend yield
2.07%
F-score
7/9
Altman Z
1.84
Beneish M
−2.64
Dividend safety
67/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Becton, Dickinson and Company (BDX) EV/EBITDA

Alert me on EV/EBITDA

As of 16 October 2026, Becton, Dickinson and Company (BDX) trades at a EV/EBITDA of 13.7×. Over the past ten years it has ranged from 10.1× (January 2015) to 33.5× (June 2018); the current reading is higher than 21% of that period. That is below the Medical Instruments & Supplies industry median of 14.6× and above the Healthcare sector median of 9.2×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 11.7× (22.08%)
FY2024 15.1× (7.01%)
FY2023 16.2× 16.67%
FY2022 13.9× (10.16%)
FY2021 15.5× (26.99%)
FY2020 21.2× 21.63%
FY2019 17.4× (13.35%)
FY2018 20.1× 40.04%
FY2017 14.3× (3.90%)
FY2016 14.9× (3.73%)

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 11.4× (4.46%)
Mar 2026 11.9× 3.16%
Dec 2025 11.6× (1.54%)
Sep 2025 11.7× (5.14%)
42 more quarters

Against its own ten years

Low 10.1× High 33.5×
Ten-year median 15.6×
Current reading's percentile 21

EV/EBITDA against peers

Company EV/EBITDA
MDLN Medline Inc. compare 4.1×
SOLV Solventum Corporation compare 7.6×
ALC Alcon compare 13.0×
BDX Becton, Dickinson and Company 13.7×
BAX Baxter International Inc. compare 14.0×
RMD ResMed Inc. compare 15.8×
WST West Pharmaceutical Services, Inc. compare 31.2×
ISRG Intuitive Surgical, Inc. compare 34.3×
RGEN Repligen Corporation compare 60.2×
Medical Instruments & Supplies industry median 14.6×
Healthcare sector median 9.2×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on BDX